Infection and transmission dynamics of rKSHV.219 in primary endothelial cells

Journal of Virological Methods

Volumn 193, Issue 1, 2013, Pages 251-259

  Jeffery, Hannah C ^a   Wheat, Rachel L ^a   Blackbourn, David J ^a   Nash, Gerard B ^a   Butler, Lynn M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Endothelial cell; Kaposi's sarcoma associated herpes virus; Rkshv.219

Indexed keywords

CELL MEMBRANE MARKER; GREEN FLUORESCENT PROTEIN; LATENCY ASSOCIATED NUCLEAR ANTIGEN; LATENCY ASSOCIATED NUCLEAR ANTIGEN 1; RED FLUORESCENT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL HETEROGENEITY; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNOCYTOCHEMISTRY; LATENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN ENGINEERING; PROTEIN EXPRESSION; UMBILICAL VEIN; VIRUS CELL INTERACTION; VIRUS TRANSMISSION;

ENDOTHELIAL CELL; KAPOSI'S SARCOMA-ASSOCIATED HERPES VIRUS; RKSHV.219;

CELLS, CULTURED; ENDOTHELIAL CELLS; FLUORESCENCE; GREEN FLUORESCENT PROTEINS; HERPESVIRUS 8, HUMAN; HUMANS; STAINING AND LABELING; TIME FACTORS; VIROLOGY; VIRUS LATENCY; VIRUS REPLICATION;

EID: 84879998566     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2013.06.001     Document Type: Article

References (15)

1. Adang L.A., Parsons C.H., Kedes D.H. Asynchronous progression through the lytic cascade and variations in intracellular viral loads revealed by high-throughput single-cell analysis of Kaposi's sarcoma-associated herpesvirus infection. J. Virol. 2006, 80:10073-10082.
2. Billstrom M.A., Lehman L.A., Scott Worthen G. Depletion of extracellular RANTES during human cytomegalovirus infection of endothelial cells. Am. J. Respir. Cell Mol. Biol. 1999, 21:163-167.
3. Butler L.M., Jeffery H.C., Wheat R.L., Rae P.C., Townsend K., Alkharsah K.R., Schulz T.F., Nash G.B., Blackbourn D.J. Kaposi's sarcoma-associated herpesvirus infection of endothelial cells inhibits neutrophil recruitment through an interleukin-6-dependent mechanism: a new paradigm for viral immune evasion. J. Virol. 2011, 85:7321-7332.
4. Ciufo D.M., Cannon J.S., Poole L.J., Wu F.Y., Murray P., Ambinder R.F., Hayward G.S. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures. J. Virol. 2001, 75:5614-5626.
5. DeMarchi J.M., Kaplan A.S. Physiological state of human embryonic lung cells affects their response to human cytomegalovirus. J. Virol. 1977, 23:126-132.
6. DiMaio T.A., Gutierrez K.D., Lagunoff M. Latent KSHV infection of endothelial cells induces integrin beta3 to activate angiogenic phenotypes. PLoS Pathog. 2011, 7:e1002424.
7. Flore O., Rafii S., Ely S., O'Leary J.J., Hyjek E.M., Cesarman E. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 1998, 394:588-592.
8. Ganem D. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu. Rev. Pathol. 2006, 1:273-296.
9. Grundhoff A., Ganem D. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J. Clin. Invest. 2004, 113:124-136.
10. Ingram D.A., Mead L.E., Tanaka H., Meade V., Fenoglio A., Mortell K., Pollok K., Ferkowicz M.J., Gilley D., Yoder M.C. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004, 104:2752-2760.
11. Kedes D.H., Lagunoff M., Renne R., Ganem D. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J. Clin. Invest. 1997, 100:2606-2610.
12. Mesri E.A., Cesarman E., Boshoff C. Kaposi's sarcoma and its associated herpesvirus. Nat. Rev. Cancer 2010, 10:707-719.
13. Moses A.V., Fish K.N., Ruhl R., Smith P.P., Strussenberg J.G., Zhu L., Chandran B., Nelson J.A. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J. Virol. 1999, 73:6892-6902.
14. Pyeon D., Pearce S.M., Lank S.M., Ahlquist P., Lambert P.F. Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog. 2009, 5:e1000318.
15. Vieira J., O'Hearn P.M. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 2004, 325:225-240.